BORTEZOMIB is a Intravenous; Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Zydus Lifesciences Limited. The primary component is Bortezomib.
Product ID | 70771-1708_a7ff2205-566b-4fb5-8f33-bf73377ee093 |
NDC | 70771-1708 |
Product Type | Human Prescription Drug |
Proprietary Name | BORTEZOMIB |
Generic Name | Bortezomib |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
Marketing Start Date | 2022-05-02 |
Marketing Category | ANDA / |
Application Number | ANDA210204 |
Labeler Name | Zydus Lifesciences Limited |
Substance Name | BORTEZOMIB |
Active Ingredient Strength | 1 mg/mL |
Pharm Classes | Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-05-02 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9098 | bortezomib | bortezomib |
0409-1700 | Bortezomib | Bortezomib |
0409-1703 | BORTEZOMIB | BORTEZOMIB |
0409-1704 | BORTEZOMIB | BORTEZOMIB |
0781-3258 | bortezomib | bortezomib for injection |
10019-991 | BORTEZOMIB | bortezomib |
25021-244 | BORTEZOMIB | BORTEZOMIB |
43598-426 | Bortezomib | Bortexomib |
43598-865 | Bortezomib | Bortexomib |
50742-484 | Bortezomib | Bortezomib |
51817-586 | Bortezomib | bortezomib |
55150-337 | BORTEZOMIB | BORTEZOMIB |
60505-6050 | BORTEZOMIB | bortezomib |
63323-721 | Bortezomib | Bortezomib |
63323-821 | Bortezomib | Bortezomib |
67184-0530 | Bortezomib | Bortezomib |
68001-534 | Bortezomib | Bortezomib |
68001-540 | Bortezomib | Bortezomib |
68001-541 | Bortezomib | Bortezomib |
70511-161 | Bortezomib | bortezomib |
70511-162 | Bortezomib | bortezomib |
70710-1411 | BORTEZOMIB | BORTEZOMIB |
70771-1708 | BORTEZOMIB | BORTEZOMIB |
70860-225 | Bortezomib | bortezomib |
71288-118 | Bortezomib | Bortezomib |
72205-183 | Bortezomib | Bortezomib |
72266-243 | Bortezomib | bortezomib |
72266-244 | Bortezomib | bortezomib |
63020-049 | VELCADE | bortezomib |